| pubmed-article:7052115 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7052115 | lifeskim:mentions | umls-concept:C0030095 | lld:lifeskim |
| pubmed-article:7052115 | lifeskim:mentions | umls-concept:C0012472 | lld:lifeskim |
| pubmed-article:7052115 | lifeskim:mentions | umls-concept:C0259787 | lld:lifeskim |
| pubmed-article:7052115 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:7052115 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:7052115 | lifeskim:mentions | umls-concept:C0205171 | lld:lifeskim |
| pubmed-article:7052115 | lifeskim:mentions | umls-concept:C0042264 | lld:lifeskim |
| pubmed-article:7052115 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:7052115 | pubmed:dateCreated | 1982-12-3 | lld:pubmed |
| pubmed-article:7052115 | pubmed:abstractText | In a randomized controlled study of 100 women of low parity and favourable induction features, induction of labour by means of a single vaginal tablet containing 3 mg of prostaglandin E2 (PGE2) was compared with the conventional method of amniotomy and intravenous oxytocin. Four of the patients (8%) who received the prostaglandin tablet required additional intravenous oxytocin to achieve delivery. The prostaglandin group had a longer mean overall induction-delivery interval but a shorter amniotomy-delivery interval than the oxytocin group. One patient in the PGE2 group and two in the oxytocin group required caesarean section. The PGE2 treated patients expressed a higher level of satisfaction with their method of induction, they required less analgesia, had less blood loss at delivery and their babies had a lower incidence of neonatal jaundice. | lld:pubmed |
| pubmed-article:7052115 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7052115 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7052115 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7052115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7052115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7052115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7052115 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7052115 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7052115 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:7052115 | pubmed:issn | 0306-5456 | lld:pubmed |
| pubmed-article:7052115 | pubmed:author | pubmed-author:StewartPP | lld:pubmed |
| pubmed-article:7052115 | pubmed:author | pubmed-author:KennedyJ HJH | lld:pubmed |
| pubmed-article:7052115 | pubmed:author | pubmed-author:CalderA AAA | lld:pubmed |
| pubmed-article:7052115 | pubmed:author | pubmed-author:BarlowD HDH | lld:pubmed |
| pubmed-article:7052115 | pubmed:author | pubmed-author:HillalGG | lld:pubmed |
| pubmed-article:7052115 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7052115 | pubmed:volume | 89 | lld:pubmed |
| pubmed-article:7052115 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7052115 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7052115 | pubmed:pagination | 704-7 | lld:pubmed |
| pubmed-article:7052115 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:meshHeading | pubmed-meshheading:7052115-... | lld:pubmed |
| pubmed-article:7052115 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:7052115 | pubmed:articleTitle | Induction of labour: a comparison of a single prostaglandin E2 vaginal tablet with amniotomy and intravenous oxytocin. | lld:pubmed |
| pubmed-article:7052115 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7052115 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7052115 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7052115 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
